System Issue At CVS Caremark Leaves Patients Stranded Without Medications

This article states that CVS/Caremark, last year processed ONE-THIRD of all prescriptions. “processed” is a VERY VAGUE TERM, the PBM can reject a claim for various reasons, prior authorization required, days supply limits, they can and do determine how much the pharmacy is going to be paid and many pay the pharmacy – especially independents – less than the cost the pharmacy has to pay to the drug wholesaler for the medication. There is only about 5 PBM’s that control some 80%-90% of the entire out pt medication market.  The claim of 6.9 billion claims seem to be a “bit higher” than the number of prescriptions that are routinely claimed to be filled by pharmacies… That number is typically stated in the low 4 billion number. So is Caremark counting all claim rejections as “claims processed”. I would suspect that Caremark gets some $$ every time they handle a claim, even if it involves a rejection. That number would suggest that Caremark is REJECTING about ONE-THIRD of all claims filed.

System Issue At CVS Caremark Leaves Patients Stranded Without Medications

https://finance.yahoo.com/news/system-issue-cvs-caremark-leaves-140608072.html

Starting Monday morning, patients covered by CVS’s Caremark business experienced a halt in prescription processing, leaving some without their medications.

CVS Health Corp’s (NYSE: CVS) unit, Caremark, noted an “unexpected system slowdown” in a letter dispatched to pharmacists on Monday.

This issue affected all types of businesses managed by CVS Caremark, which funds prescriptions at thousands of drugstores, including those beyond the company’s outlets.

On Tuesday, a CVS Health spokesperson mentioned that a system issue impacted Caremark’s prescription billing and e-prescriptions. While the system is now operational, there might be temporary delays due to a backlog of prescriptions, Wall Street Journal reported. The cause of the issue was not disclosed.

According to the Drug Channels Institute, CVS Caremark, which processed 2.3 billion claims in the previous year, represents about a third of the market.

Carter High, co-owner of Best Value Pharmacies, reported prescription processing issues via CVS Caremark’s system starting Monday morning at his stores in the Fort Worth area.

High faced difficulties checking customers’ coverage, and he couldn’t determine whether the prescription would be paid for or how much the customer should be charged out-of-pocket.

Consequently, some customers were asked to return the following day unless they were willing to pay the full cost of the prescription up front.

The outage persisted throughout Monday, but prescriptions were being processed again by Tuesday morning, albeit with some delays.

Are Federal Guidelines for Prescribing Opioids Hurting Patients With Chronic Pain?

Are Federal Guidelines for Prescribing Opioids Hurting Patients With Chronic Pain?

I wonder how many chronic pain pts want to get their pain management advice from a JOURNALIST ?

AMA MUST EXPOSE OPIOID TASK FORCE LEGITIMACY

Qing McGaha, MD, 55, is the next minority physician to be targeted by the rogue US Department of Justice. Dr. Qing McGaha is a PM&R physician in Clearwater, FL. She received her medical degree from Tianjin Medical University in China, but then came to America for…

TAMPA BAY PAIN DR. QING MCGAHA, MD., INDICTMENT AND CONVICTION RAISES ALARMING CONCERNS AND SUSPICIONS OF AUSA KENNETH POLITE’s OPIOID TASK FORCE LEGITIMACY (THE AMA MUST GET INVOLVED)

King Sooper: a Kroger company: Worker Fired After Recording Laundry Detergent Theft

#Kroger As a stockholder, member of your boast program, and a loyal customer. I am highly disappointed in how the employee at King Snooper was treated (fired) when he did nothing more than do a video of 3 males stealing merchandise and getting a shot of their license plate. We are retired and my wife is handicapped/disabled and your boost program is very important to us, but we depend on our stock portfolio (appreciation/dividends) to fill in the gap between our social security money and our day-to-day living costs. How many other people in our demographic, will be forced to reconsider owning your stock and patronizing your store(s). When we see, your corporate policies seem to allow people just walk out of your stores, with hundreds of dollars of merchandise without consequences? I put this as a message on their Kroger FB page https://www.facebook.com/Kroger

Cross-country bike ride raising awareness of chronic pain travels through Eastern Kentucky

Cross-country bike ride raising awareness of chronic pain travels through Eastern Kentucky

https://wchstv.com/news/local/cross-country-bike-ride-to-shed-light-on-chronic-pain-travels-through-eastern-kentucky#

An Arizona man is riding a motorized bicycle across the country to raise awareness for people who suffer from chronic pain. Friday morning his travels took him through Eastern Kentucky.

Joe Jackson calls his trip “Lisa’s Ride.” She is Jackson’s late wife who passed away last year. He is making the trip in her honor, and began the journey in Lake City, Florida

“I am making this trip so other people don’t suffer like my beloved Lisa did,” Jackson told Eyewitness News.

Lisa Jackson died last year of a chronic pain caused by a rare disease comparable to metastatic bone cancer. Jackson believes his wife would still be alive today had her doctor listened to them.

Lisa Jackson passed away last year of a rare disease comparable to metastatic bone cancer. (Photo Courtesy of Joe Jackson)

“Lisa had 3 1/2 decades of progression in 3 1/2 years. That’s insane,” Jackson said. “Nobody should have to go through that, nor should anybody be forced to endure that kind of pain, especially when we have FDA-approved medications.”

Jackson said there are doctors who take the time to listen to their patients.

“But the vast majority of them, from my own personal experience and the experience of thousands of others I have met on this trip, it’s the exact opposite,” Jackson said. “We are treated as a number and a way to finance their practice.”

Since beginning his trip, Jackson has made more than 30 stops, listening and documenting stories of chronic pain from the public and advocates.

“About 90% of the people out there advocating are the people like myself, sufferers ourselves,” Jackson said.

Jackson has made more than 30 stops on his trip, documenting stories of chronic pain from the public and advocates. (WCHS)

Jackson has been diagnosed with an aggressive form of multiple sclerosis and Parkinson’s disease. He believes the trip is probably speeding up the disease and he may not be alive this time next year, but he still presses on in honor of his late wife.

“I hope she is proud and happy that I’m doing this,” Jackson added.

From Grayson, Jackson’s next stop is Cambridge, Kentucky near Louisville. The trip is scheduled to end this fall in Flagstaff, Arizona.

Home care industry group sues to block 2023, 2024 Medicare payment cuts it claims are unlawful

Home care industry group sues to block 2023, 2024 Medicare payment cuts it claims are unlawful

https://www.fiercehealthcare.com/providers/home-care-industry-group-sues-block-cms-2023-2024-payment-cuts-it-says-are-unlawful

Days after the Biden administration proposed hundreds of millions in 2024 pay cuts for home health providers, an industry association is suing the government over similar adjustments at the heart of 2023’s final rule.

Filed Wednesday in the U.S. District Court for the District of Columbia, The National Association for Home Care and Hospice (NAHC)’s complaint petitions the court to strike down and vacate the Home Health Prospective Payment System (Home Health PPS) final rule for 2023, and to withhold applying the 2024 proposal released last Friday.

NAHC alleged that the pay cuts included in both rules contradict directions Congress gave the Centers for Medicare and Medicaid Services (CMS) in the Bipartisan Budget Act of 2018, “arbitrarily and capriciously” set payment rate adjustments that “will result in substantial financial harm to numerous home health agencies across the country” and, ultimately, stymie access to home care.

“We have done everything possible to get Medicare to understand the disastrous consequences of its actions,” NAHC President William Dombi said in a release. “We have presented hard facts, deep legal analyses, and extensive data to Medicare that demonstrate the errors in its policies to no avail.  As a last resort, we have filed this lawsuit to protect Medicare beneficiaries and the home health agencies that care for them.”

The 2018 law aimed to distance payment incentives away from the volume of therapy sessions delivered and, to account for resulting changes in care patterns, required CMS to create and periodically confirm payment assumptions about behavioral changes in home health, which it began to do in 2020.

In the CY2023 Home Health PPS, that permanent behavior adjustment of -3.925% (-$635 million) largely offset other payment increases and left aggregate Medicare payments to home health agencies at an estimated 0.7% ($125 million) year-over-year increase, per CMS.

In the CY2024 Home Health PPS proposal released last week, CMS floated a -5.1% ($870 million) permanent behavior assumption adjustment that would outpace other upward adjustments for an estimated aggregate change of -2.2% (-$375 million) compared to CY2023. That proposal has been largely panned by industry groups that said it would lead to reduced beneficiary access to home healthcare services.

NAHC was among those critics and took their dissent to a new level with Wednesday’s filing. In it, the group noted that Congress instructed CMS to make its adjustments in a way that would be “budget-neutral, ensuring that the adoption of the new payment system would result in neither a net increase nor a net decrease in total Medicare payments.”

CMS’ approach “unlawfully rebases home health payment rates to reduce overall expenditures,” the group wrote.

Additionally, the CY2023 final rule still “ties the payment adjustment to the amount of therapy actually provided” against Congress’ intent, NAHC alleged, and despite CMS’ messaging “does not measure either assumed or actual behavior changes at all, and it certainly does not calculate the difference of their impact on aggregate expenditures.”

Unless they are corrected, CMS’ approach to home health payment adjustments “will leave numerous Medicare beneficiaries with limited or no access to vital home health services, directly contrary to Congress’s intent,” the group wrote. “Instead of reforming Medicare reimbursement rates to be more patient-centric and less therapy-centric, as Congress directed, the Secretary’s final rule will disrupt the market, penalize home health agencies that relied on Congress’s statutory reforms, and prevent beneficiaries from accessing the essential home health services they need.”

NAHC’s complaint highlighted specific member organizations—Home Health Services of Mary Lanning Healthcare, in Nebraska, and Androscoggin Home Healthcare + Hospice, in Maine—that had their Medicare revenues reduced by hundreds of thousands and millions, respectively, under the payment model at issue. An accompanying release also points to a 500,000-person reduction in the number of Medicare patients who have used home health services since 2020.

“Home health agencies again must withstand billions of dollars in payment cuts as cost of care continues to rise and still be expected to deliver the care to which our patients are entitled to as a Medicare benefit.”  Ken Albert, Chairman of NAHC, and CEO of Androscoggin Home HealthCare + Hospice, said in a release. “Since these cuts took effect in January, providers have reduced service areas, turned away thousands of patients, and halted the use of innovative technologies in order to stay afloat and serve some patients.”

APDF Real Pain, Real Talk Podcast Episode 3 with guest Pharmacist Steve Ariens

Currently playing episode
The American Pain & Disability Foundation (APDF) is a nonprofit 501(c)(3) organization that advocates for patients, works on legislation, offers a support group for patients in need, & more. Join us when we interview our incredible guests! If you’re interested & able to make a donation, please visit our website at https://www.4apdf.org. We welcome you to download & play the “Real Pain, Real Talk”©™ podcast for personal use, but the podcast, its episodes, contents, images, & affiliated materials are solely the intellectual property of APDF. All rights reserved.

Corners are cut to dispense prescriptions, CVS employee tells Ohio Board of Pharmacy

Corners are cut to dispense prescriptions,” CVS employee tells Ohio Board of Pharmacy

https://ohiocapitaljournal.com/2023/07/07/corners-are-cut-to-dispense-prescriptions-cvs-employee-tells-ohio-board-of-pharmacy/

At least eight CVS pharmacies in Ohio are so understaffed that they have seen rampant turnover, dirty conditions, lack of controls over dangerous drugs and wait times as long as a month for prescriptions, according to reports by the Ohio Board of Pharmacy. 

The waits have been so long that a harried CVS pharmacist in Wooster said he was “actively triaging prescriptions to ensure lifesaving, life-sustaining medications are filled in a timely manner.” 

In one case, pharmacy workers told inspectors they begged their superiors — unsuccessfully — to close their pharmacies so they could catch up. In another, a pharmacy did intermittently close, making it impossible for patients to get their medicines during the closures.

In another instance, Board of Pharmacy inspectors couldn’t tell if employees were stealing controlled substances. In yet another, they couldn’t tell if CVS was improperly billing insurers for scripts it didn’t fill. 

And in several additional cases, inspectors repeatedly found expired and adulterated drugs on pharmacy shelves and filled prescriptions that gave patients the wrong instructions.

“Corners are cut to dispense prescriptions,” at least one employee at Toledo’s CVS store No. 10246 told investigators last year. Workers there added, “Supervisors/District Managers do not respond to staff calls for help,” the report said.

The accounts come from inspection reports going back to 2020 that the Capital Journal obtained under the Ohio Public Records Act. At least some of the inspections came in response to patient complaints to the board, which licenses Ohio pharmacies.

The inspections come after CVS — already the nation’s largest pharmacy retailer — has for years bought up competitors, closed them and moved the prescriptions of the closed pharmacies to existing CVS stores. Critics raised concerns about the practice, known as “buy and close,” at least as early as 2019.

“Staff at this location was not increased,” a pharmacist at Dayton’s CVS store No. 2528 said last September after the store had absorbed two other closed pharmacies’ prescriptions. She quit the following month.

For its part, CVS didn’t answer questions about specific allegations in the reports, which it referred to as “isolated incidents.”

“We’re working with the Board of Pharmacy to resolve allegations of isolated incidents, most of which date back a year or more,” Amy Thibault, director of communications for CVS Pharmacy said in an email Wednesday. “The health and well-being of our patients is our number one priority.”

Rampant turnover

Pharmacies across the country found themselves under siege as the coronavirus pandemic took hold in the spring of 2020. They were conducting tests and, when they became available, providing COVID vaccines in addition to already administering those for flu and shingles.

At the same time, some pharmacy employees were reluctant to work face-to-face with the public in a health care setting — especially before there were vaccines against a disease that has killed more than 1 million Americans.

But according to the Board of Pharmacy reports, turnover in the CVS stores they investigated seemed particularly bad. And it seemed to be linked to stress from overwork — as well as the parent corporation’s inability or unwillingness to do anything about it.

For example, when an inspector arrived at CVS store No. 2063 in Canton on Sept. 13, 2020, the staff was so harried that it took them 20 minutes to even acknowledge the inspector. The staff said that the store had lost a pharmacist and six technicians “within a short time.”

As workers scrambled, they sweltered in a pharmacy in which the air conditioning unit was broken and an alarm in a drug cooler failed to warn them that it was too warm at 46.4 degrees Fahrenheit. 

“Pharmacy staff and an assistant store manager stated they have asked district leaders to close the store down temporarily to get caught up filling prescriptions as well as clean and organize the pharmacy, but this request was denied,” the report said.

When an inspector returned to the pharmacy on Oct. 29, 2021, things had only gotten worse.

“All pharmacy staff that was present for the September 2021 inspection quit or transferred out of CVS #2063,” the report said.

Even more alarmingly, understaffing there created delays that easily could have harmed patients’ health — despite workers’ best efforts to “triage” which prescriptions to fill first. 

“The pharmacy was over a month behind in filling prescriptions,” the report said.

Especially bad at CVS

During the pandemic, conditions were universally difficult for pharmacies, but CVS might have been a special case.

An owner of an independent pharmacy in Northern Ohio said things were rough for everybody, and that he’s still having trouble keeping enough pharmacy technicians on his staff. But, he said, that never led him to consider temporary closures, or anything like the delays filling prescriptions and other problems seen at some CVS stores.

The pharmacist depends on CVS Caremark — the corporation’s gargantuan pharmacy benefit manager — for his business and asked not to be named. But, he said, he’s talked to CVS pharmacists who have been under pressure so great that it affected their mental health.

The stress appeared to extend even to the upper ranks of CVS’s pharmacy operation.

In July 2021, Ken Sidwell became leader of the district which includes Canton CVS store #2063. When he was interviewed by the Board of Pharmacy, he said the store was short-staffed when he got the job. 

Just three months later, Sidwell was gone. On Oct. 29, 2021, the new district leader, Kenneth Cook, told the Board of Pharmacy that the store “is in the process of hiring new pharmacy staff as well as transferring staff from an overstaffed CVS location.”

CVS spokeswoman Thibault said the company’s policies ensure that its stores are not dangerously short of pharmacy workers.

“Decisions about staffing, labor hours, workflow process, technology enhancements and other operational factors are made to ensure we have appropriate levels of staffing and resources in place at our pharmacies,” she said. “We have comprehensive policies and procedures in place to support prescription safety and we continue to make important strides, including using technology to support our pharmacy teams.”

Buy and close

Not only is CVS the nation’s largest pharmacy retailer, its parent corporation also owns Aetna, a top-10 insurer. It’s also buying up medical centers and physicians practices, helping to make it the nation’s sixth-largest corporation

And crucially for pharmacies everywhere, CVS owns the nation’s largest pharmacy benefit manager, CVS Caremark. It and Express Scripts and OptumRx are estimated to control more than 80% of the marketplace and they’re under investigation for possible anti-competitive practices by the Federal Trade Commission. 

Pharmacy benefit managers, or PBMs, act as middlemen for insurers in the drug supply chain. They decide which drugs are covered, so they have great power to negotiate huge, non-transparent rebates and other discounts from drugmakers.

At the same time, they create pharmacy networks. And, because they control access to so many millions of patients, most small-chain and independent pharmacists think they have little choice about contracting with them on whatever terms the big PBMs choose. 

“Take-it-or-leave-it” contracts, the pharmacists call them.

CVS has long said that it maintains strict firewalls between its retail and PBM operations, but small pharmacy operations in Ohio and elsewhere aren’t so sure.

After seeing their reimbursements from CVS Caremark plummet in late 2016, CVS’s “Acquisition Unit” in 2017 sent many of its competitor pharmacies letters saying that it knew times were hard for them and offering to buy them out.

In many instances, CVS didn’t put its sign on the store it had just purchased. CVS instead closed the stores and folded all of their prescriptions into an existing CVS pharmacy. 

Some pharmacists call the practice “buy and close.”

In 2019, when CVS bought 20 stores owned by Medina-based Ritzman Pharmacy and closed all but three, critics said it was classic buy-and-close.

Two of the now-closed pharmacies were in Wooster, one of the cities in which inspectors now find problems in a still-open CVS pharmacy. Three more — in Sugarcreek, Millersburg and Dover — were to the rural south of Canton and Massillon, where CVS stores found themselves seriously stretched in the years since.

Mount Vernon-based Conway’s Pharmacy in 2019 partnered with Knox County to open a pharmacy in Danville on the edge of Amish Country after CVS bought and closed the only pharmacy there a few years earlier. The closure meant that Danville residents — many poor, disabled or both — had to drive 20 minutes or more to get their medicines or to consult with a pharmacist.

Such practices have fueled fears that pharmacy deserts are being created in Ohio and elsewhere.

Lack of accountability

The constant churn in CVS staffing found by Board of Pharmacy investigators led to breakdowns in accounting for dangerous drugs, including opioids, the inspection reports said.

For example, between June 10 and Sept. 22, 2022 Dayton’s CVS store No. 2528 reported 75 oxycodone, 100 hydromorphone and 70 amphetamine pills were missing. In each instance, “CVS Pharmacy was unable to determine a reason for the loss,” the inspection report said.

For most of that period, no “Responsible Person” was in charge. 

The role is as the name implies. The Ohio Administrative Code says, “The Responsible Person shall be responsible for the practice of the profession of pharmacy, including, but not limited to, the supervision and control of dangerous drugs as required…”

That person would normally be the managing pharmacist at a drugstore. But for months after May 26, 2022, there was no such person at the Dayton CVS, according to the report. Inspectors interviewed pharmacist Jean Getter, who said she was asked to serve as temporary manager after the previous Responsible Person, pharmacist Tyler Philo, left.

Getter said that even though she wasn’t the Responsible Person, she asked for help sorting out the safe that contained controlled substances because “it was a mess.”

“She asked the previous Responsible Person and also the District Leader about cleaning up the safe, but it never happened,” the report said.

An inventory of dangerous drugs is supposed to be conducted whenever there is a change of Responsible Person at a pharmacy, but that kept not happening at the Dayton CVS, Getter said.

“No one ever became the permanent Responsible Person, which is why Ms. Getter left CVS in August,” the report said.

Then Pharmacy Board investigators interviewed Philo, the previous Responsible Person and learned something even more confounding.

“He was not aware (four months after he left that) he was still listed as the Responsible Person for CVS Pharmacy #2528,” the report said.

Controlled substances

Board of Pharmacy inspectors also found serious potential problems in CVS stores’ tracking controlled drugs — including the kinds of drugs that have fueled Ohio’s opioid crisis.

Some problems were as simple as leaving deliveries of dangerous drugs at the front of the store for nine hours because pharmacy staffers were too busy to get them. But others might have been more sophisticated.

At Toledo CVS store No. 10246, inspectors conducted, “Multiple audits consisting of 241 controlled substances were conducted by representatives from the Board between on or about November 11, 2021 and on or about April 27, 2022.”

In 42% of cases, they found that too much or too little of the drugs had been provided. They discovered “significant losses” of amphetamines and the painkiller tramadol. 

“Additional losses and overages were discovered, some of which were reported to the board, but many were not reported at all, or not reported in a timely fashion,” report said. It added that auditing what happened to controlled substances was difficult “because CVS records showed multiple significant inventory adjustments and changes in medication counts…”

Counterintuitively, investigators found that on some days when controlled substances were delivered to the Toledo pharmacy, inventories of the drugs actually went down. That might indicate “diversion” — a term used in the industry for stealing drugs.

“It remains questionable if counts were entered as negative numbers in error, or if staff were entering negative numbers to mask the diversion of drugs received on that day,” the report said.

In the same store, inspectors discovered chaotic conditions.

On repeated visits, inspectors found “expired/adulterated” medications on pharmacy shelves and workers told them they hadn’t had time to address the issue. The inspectors also painted a picture of general chaos.

“Shelving for drug storage had collapsed and medications were crushed beneath the shelving units. Drug stock crowded the aisle floors,” the report said, adding, “The counter used for non-sterile compounding was overflowing with (over-the-counter) medications and return-to-stock bottles. Staff food and beverages were also stored in this area. Moldy/rotting food was found on the counter.”

Beyond delays and lacking controls, inspectors found another problem at the store that could endanger patients’ health.

Inspectors on March 3, 2022 reviewed 49 prescriptions filled at the store. They found that seven “had errors in the directions to patients.”

And when inspectors talked to employees, they heard echoes of the complaints at other CVS pharmacies they’d visited.

  • “The pharmacy is always short staffed.”
  • “The workplace was described as hectic. There is no downtime to catch up on tasks.”
  • “Morale among store employees is poor.”

Delays and questions about improper billing

When inspectors visited CVS store No. 8248 in Massillon in late 2021, they found a pharmacy so understaffed that “the pharmacy would close intermittently,” meaning “patients were unable to pick-up/receive their prescriptions.”

They again found confusion over who was legally responsible.

“The Responsible Person, Abbey Yannerella, was listed as the Responsible Person at this location as well as CVS #2063; however, she was no longer working at” the Massillon store, the report said.

They found something else that raised serious questions. 

The store in October 2021 had more than 2,000 prescriptions waiting to be filled, the oldest of which had been waiting for 13 days. A month later, the pharmacist on duty told inspectors that after scripts go unfilled for 14 days, they’re “deleted from the queue.”

The inspectors found one such prescription that was labeled “Print Ready.”

“The prescription’s status indicating ‘Print Ready’ means the prescription was processed through insurance,” the report said. “When a prescription is deleted from the queue, the pharmacy does not reverse the insurance claim.”

CVS didn’t respond directly when asked how often scenarios like this occur — or whether it routinely bills insurers for prescriptions it fails to fill for two weeks and then deletes from its system.

On Nov. 28, 2021 a new Responsible Person, pharmacist Nayan Patel, had been named. He told investigators that the deletion of prescriptions after 14 days was a requirement of the U.S. Centers for Medicare and Medicaid Services. He added that the scripts are placed back into the queue after their deletion.

However, “When asked to explain this process further, he could not elaborate,” the report said.

Then on Feb. 4, 2022, the Board of Pharmacy learned that Patel was Responsible Person for two CVS pharmacies without the special permission required by the board. When the board notified a CVS district leader of that fact, “The district leader notified the board Mr. Patel is no longer the Responsible Person of” Massillon CVS store No. 8248, the report said.

Penalties

The board has notified CVS that it can impose penalties ranging from fines to revoking their licenses as a “Terminal Distributor of Dangerous Drugs” at each of the locations in which it found violations.

So far, CVS store #3613 in Columbus received a $1,000 fine and a written reprimand last August, Board of Pharmacy spokesman Cameron McNamee said in an email Thursday. The violations outlined in that report seem considerably less severe than those found in some other CVS pharmacies.

Violations found at CVS’s Canton store No. 2063 — where staff turnover was particularly rampant — are slated to be considered at the board’s Nov. 7-8 meeting McNamee said.

Hearings for the other stores are yet to be schedule

How Often Do Health Insurers Say No to Patients? No One Knows

How Often Do Health Insurers Say No to Patients? No One Knows

https://www.propublica.org/article/how-often-do-health-insurers-deny-patients-claims

It’s one of the most crucial questions people have when deciding which health plan to choose: If my doctor orders a test or treatment, will my insurer refuse to pay for it?

After all, an insurance company that routinely rejects recommended care could damage both your health and your finances. The question becomes ever more pressing as many working Americans see their premiums rise as their benefits shrink.

The lack of transparency is especially galling because state and federal regulators have the power to fix it, but haven’t.

ProPublica, in collaboration with The Capitol Forum, has been examining the hidden world of insurance denials. A previous story detailed how one of the nation’s largest insurers flagged expensive claims for special scrutiny; a second story showed how a different top insurer used a computer program to bulk-deny claims for some common procedures with little or no review.

The findings revealed how little consumers know about the way their claims are reviewed — and denied — by the insurers they pay to cover their medical costs.

When ProPublica set out to find information on insurers’ denial rates, we hit a confounding series of roadblocks.

In 2010, federal regulators were granted expansive authority through the Affordable Care Act to require that insurers provide information on their denials. This data could have meant a sea change in transparency for consumers. But more than a decade later, the federal government has collected only a fraction of what it’s entitled to. And what information it has released, experts say, is so crude, inconsistent and confusing that it’s essentially meaningless.

The national group for state insurance commissioners gathers a more detailed, reliable trove of information. Yet, even though commissioners’ primary duty is to protect consumers, they withhold nearly all of these details from the public. ProPublica requested the data from every state’s insurance department, but none provided it.

Two states collect their own information on denials and make it public, but their data covers only a tiny subset of health plans serving a small number of people.

The minuscule amount of details available about denials robs consumers of a vital tool for comparing health plans.

“This is life and death for people: If your insurance won’t cover the care you need, you could die,” said Karen Pollitz, a senior fellow at KFF (formerly known as the Kaiser Family Foundation) who has written repeatedly about the issue. “It’s all knowable. It’s known to the insurers, but it is not known to us.”

The main trade groups for health insurance companies, AHIP (formerly known as America’s Health Insurance Plans) and the Blue Cross Blue Shield Association, say the industry supports transparency and complies with government disclosure requirements. Yet the groups have often argued against expanding this reporting, saying the burdens it would impose on insurance companies would outweigh the benefits for consumers.

“Denial rates are not directly comparable from one health plan to another and could lead consumers to make inaccurate conclusions on the robustness of the health plan,” Kelly Parsons, director of media relations for the Blue Cross Blue Shield Association, said in an email.

The trade groups stress that a substantial majority of patient claims are approved and that there can be good reasons — including errors and incomplete information from doctors — for some to be denied.

“More abstract data about percentages of claims that are approved or denied have no context and are not a reliable indicator of quality — it doesn’t address why a claim was or was not approved, what happened after the claim was not approved the first time, or how a patient or their doctor can help ensure a claim will be approved,” AHIP spokesperson Kristine Grow said in a written response to questions from ProPublica. “Americans deserve information and data that has relevance to their own personal health and circumstances.”

The limited government data available suggests that, overall, insurers deny between 10% and 20% of the claims they receive. Aggregate numbers, however, shed no light on how denial rates may vary from plan to plan or across types of medical services.

Some advocates say insurers have a good reason to dodge transparency. Refusing payment for medical care and drugs has become a staple of their business model, in part because they know customers appeal less than 1% of denials, said Wendell Potter, who oversaw Cigna’s communications team for more than a decade before leaving the industry in 2008 to become a consumer advocate.

“That’s money left on the table that the insurers keep,” he said.

At least one insurer disputes this. Potter’s former employer, Cigna, said in an email that his “unsubstantiated opinions” don’t reflect the company’s business model. In a separate written statement, Cigna said it passes on the money it saves “by lowering the cost of health care services and reducing wasteful spending” to the employers who hire it to administer their plans or insure their workers.

The few morsels insurers have served up on denials stand in stark contrast to the avalanche of information they’ve divulged in recent years on other fronts, often in response to government mandates. Starting last year, for example, insurers began disclosing the prices they’ve negotiated to pay medical providers for most services.

Experts say it’ll take similar mandates to make insurers cough up information on denials, in part because they fear plans with low denial rates would be a magnet for people who are already ailing.

“Health plans would never do that voluntarily, would give you what their claim denial rates are, because they don’t want to attract sicker people,” said Mila Kofman, who leads the District of Columbia’s Affordable Care Act exchange and previously served as Maine’s superintendent of insurance.

About 85% of people with insurance who responded to a recent KFF survey said they want regulators to compel insurers to disclose how often they deny claims. Pollitz, who co-authored a report on the survey, is a cancer survivor who vividly recalls her own experiences with insurance denials.

“Sometimes it would just make me cry when insurance would deny a claim,” she said. “It was like, ‘I can’t deal with this now, I’m throwing up, I just can’t deal with this.’”

She should have been able to learn how her plan handled claims for cancer treatment compared with other insurers, she said.

“There could be much more accountability.”

In September 2009, amid a roiling national debate over health care, the California Nurses Association made a startling announcement: Three of the state’s six largest health insurers had each denied 30% or more of the claims submitted to them in the first half of the year.

California insurers instantly said the figures were misleading, inflated by claims submitted in error or for patients ineligible for coverage.

But beyond the unexpectedly high numbers, the real surprise was that the nurses association was able to figure out the plans’ denial rates at all, by using information researchers found on the California Department of Managed Health Care’s website.

At the time, no other state or federal regulatory agency was collecting or publishing details about how often private insurers denied claims, a 2009 report by the Center for American Progress found.

The Affordable Care Act, passed the following year, was a game changer when it came to policing insurers and pushing them to be more transparent.

The law took aim at insurers’ practice of excluding people with preexisting conditions, the most flagrant type of denial, and required companies offering plans on the marketplaces created under the law to disclose their prices and detail their benefits.

A less-noticed section of the law demanded transparency from a much broader group of insurers about how many claims they turned down, and it put the Department of Health and Human Services in charge of making this information public. The disclosure requirements applied not only to health plans sold on the new marketplaces but also to the employer plans that cover most Americans.

The law’s proponents in the Obama administration said they envisioned a flow of accurate, timely information that would empower consumers and help regulators spot problematic insurers or practices.

That’s not what happened.

The federal government didn’t start publishing data until 2017 and thus far has only demanded numbers for plans on the federal marketplace known as Healthcare.gov. About 12 million people get coverage from such plans — less than 10% of those with private insurance. Federal regulators say they eventually intend to compel health plans outside the Obamacare exchanges to release details about denials, but so far have made no move to do so.

Within the limited universe of Healthcare.gov, KFF’s analyses show that insurers, on average, deny almost 1 in 5 claims and that each year some reject more than 1 in 3.

But there are red flags that suggest insurers may not be reporting their figures consistently. Companies’ denial rates vary more than would be expected, ranging from as low as 2% to as high as almost 50%. Plans’ denial rates often fluctuate dramatically from year to year. A gold-level plan from Oscar Insurance Company of Florida rejected 66% of payment requests in 2020, then turned down just 7% in 2021. That insurer’s parent company, Oscar Health, was co-founded by Joshua Kushner, the younger brother of former President Donald Trump’s son-in-law Jared Kushner

An Oscar Health spokesperson said in an email that the 2020 results weren’t a fair reflection of the company’s business “for a variety of reasons,” but wouldn’t say why. “We closely monitor our overall denial rates and they have remained comfortably below 20% over the last few years, including the 2020-2021 time period,” the spokesperson wrote.

Experts say they can’t tell if insurers with higher denial rates are counting differently or are genuinely more likely to leave customers without care or stuck with big bills.

“It’s not standardized, it’s not audited, it’s not really meaningful,” Peter Lee, the founding executive director of California’s state marketplace, said of the federal government’s information. Data, he added, “should be actionable. This is not by any means right now.”

Officials at the Centers for Medicare & Medicaid Services, which collects the denial numbers for the federal government, say they’re doing more to validate them and improve their quality. It’s notable, though, that the agency doesn’t use this data to scrutinize or take action against outliers.

“They’re not using it for anything,” Pollitz said.

Pollitz has co-authored four reports that call out the data’s shortcomings. An upshot of all of them: Much of what consumers would most want to know is missing.

The federal government provides numbers on insurers’ denials of claims for services from what the industry calls “in-network” medical providers, those who have contracts with the insurer. But it doesn’t include claims for care outside those networks. Patients often shoulder more costs for out-of-network services, ramping up the import of these denials.

In recent years, doctors and patients have complained bitterly that insurers are requiring them to get approval in advance for an increasing array of services, causing delays and, in some instances, harm. The government, however, hasn’t compelled insurers to reveal how many requests for prior authorization they get or what percent they deny.

These and other specifics — particularly about which procedures and treatments insurers reject most — would be necessary to turn the government’s data into a viable tool to help consumers choose health plans, said Eric Ellsworth, the director of health data strategy at Consumers’ Checkbook, which designs such tools.

A spokesperson for CMS said that, starting in plan year 2024, the agency will require insurers offering federal marketplace plans to submit a few more numbers, including on out-of-network claims, but there’s no timeline yet for much of what advocates say is necessary.

Another effort, launched by a different set of federal regulators, illustrates the resistance that government officials encounter when they consider demanding more.

The U.S. Department of Labor regulates upwards of 2 million health plans, including many in which employers pay directly for workers’ health care coverage rather than buying it from insurance companies. Roughly two-thirds of American workers with insurance depend on such plans, according to KFF.

In July 2016, an arm of the Labor Department proposed rules requiring these plans to reveal a laundry list of never-before-disclosed information, including how many claims they turned down.

In addition, the agency said it was considering whether to demand the dollar amount of what the denied care cost, as well as a breakdown of the reasons why plans turned down claims or denied behavioral health services.

The disclosures were necessary to “remedy the current failure to collect data about a large sector of the health plan market,” as well as to satisfy mandates in the Affordable Care Act and provide critical information for agency oversight, a Labor Department factsheet said.

Trade groups for employers, including retailers and the construction industry, immediately pushed back.

The U.S. Chamber of Commerce said complying with the proposal would take an amount of work not justified by “the limited gains in transparency and enforcement ability.” The powerful business group made it sound like having to make the disclosures could spark insurance Armageddon: Employers might cut back benefits or “eliminate health and welfare benefits altogether.”

Trade groups for health insurance companies, which often act as administrators for employers that pay directly for workers’ health care, joined with business groups to blast the proposal. The Blue Cross Blue Shield Association called the mandated disclosures “burdensome and expensive.” AHIP questioned whether the Labor Department had the legal authority to collect the data and urged the agency to withdraw the idea “in its entirety.”

The proposal also drew opposition from another, less expected quarter: unions. Under some collective bargaining agreements, unions co-sponsor members’ health plans and would have been on the hook for the new reporting requirements, too. The AFL-CIO argued the requirements created a higher standard of disclosure for plans overseen by the Labor Department. To be fair and avoid confusion, the group said, the Labor Department should put its rules on ice until federal health regulators adopted equivalent ones for plans this proposal didn’t cover.

That left the transparency push without political champions on the left or the right, former Assistant Secretary of Labor Phyllis Borzi, who ran the part of the agency that tried to compel more disclosure, said in a recent interview.

“When you’re up against a united front from the industry, the business community and labor, it’s really hard to make a difference,” she said.

By the time the Labor Department stopped accepting feedback, Donald Trump had been elected president.

One trade association for large employers pointed out that the Affordable Care Act, which partly drove the new rules, was “a law that the incoming Administration and the incoming leadership of the 115th Congress have vowed to repeal, delay, dismantle, and otherwise not enforce.”

The law managed to survive the Trump administration, but the Labor Department’s transparency push didn’t. The agency withdrew its proposal in September 2019.

A Labor Department spokesperson said the Biden administration has no immediate plan to revive it.

Ultimately, it’s the National Association of Insurance Commissioners, a group for the top elected or appointed state insurance regulators, that has assembled the most robust details about insurance denials.

The association’s data encompasses more plans than the federal information, is more consistent and captures more specifics, including numbers of out-of-network denials, information about prior authorizations and denial rates for pharmacy claims. All states except New York and North Dakota participate.

Yet, consumers get almost no access. The commissioners’ association only publishes national aggregate statistics, keeping the rest of its cache secret.

When ProPublica requested the detailed data from each state’s insurance department, none would hand it over. More than 30 states said insurers had submitted the information under the authority commissioners are granted to examine insurers’ conduct. And under their states’ codes, they said, examination materials must be kept confidential.

The commissioners association said state insurance regulators use the information to compare companies, flag outliers and track trends.

Birny Birnbaum, a longtime insurance watchdog who serves on the group’s panel of consumer representatives, said the association’s approach reflects how state insurance regulators have been captured by the insurance industry’s demands for secrecy.

“Many seem to view their roles as protectors of industry information, as opposed to enforcers of public information laws,” Birnbaum said in an email.

Connecticut and Vermont compile their own figures and make them publicly accessible. Connecticut began reporting information on denials first, adding these numbers to its annual insurer report card in 2011.

Vermont demands more details, requiring insurers that cover more than 2,000 Vermonters to publicly release prior authorization and prescription drug information that is similar to what the state insurance commissioners collect. Perhaps most usefully, insurers have to separate claims denied because of administrative problems — many of which will be resubmitted and paid — from denials that have “member impact.” These involve services rejected on medical grounds or because they are contractually excluded.

Mike Fisher, Vermont’s state health care advocate, said there’s little indication consumers or employers are using the state’s information, but he still thinks the prospect of public scrutiny may have affected insurers’ practices. The most recent data shows Vermont plans had denial rates between 7.7% and 10.26%, considerably lower than the average for plans on Healthcare.gov.

“I suspect that’s not a coincidence,” Fisher said. “Shining a light on things helps.”

Despite persistent complaints from insurers that Vermont’s requirements are time-consuming and expensive, no insurers have left the state over it. “Certainly not,” said Sebastian Arduengo, who oversees the reporting for the Vermont Department of Financial Regulation.

In California, once considered the most transparent state, the Department of Managed Health Care in 2011 stopped requiring insurance carriers to specify how many claims they rejected.

A department spokesperson said in an email that the agency follows the requirements in state law, and the law doesn’t require health plans to disclose denials.

Despite the struggles of the last 15 years, Pollitz hasn’t given up hope that one day there will be enough public information to rank insurers by their denial rates and compare how reliably they provide different services, from behavioral health to emergency care.

“There’s a name and shame function that is possible here,” she said. “It holds some real potential for getting plans to clean up their acts.”

The Patient and the Weather

https://thepatientandweather.com/

The weather matters in human health. Pressure is what everyone looks to first, but humidity, temperature,, lightning and the rate of weather change all matter. And, as you body changes, so do the weather impacts. Weather health awareness remains a constant